A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team (Q43514238)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team |
scientific article |
Statements
1 reference
A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team (English)
1 reference
X Sáez-Llorens
1 reference
R P Nelson
1 reference
P Emmanuel
1 reference
A Wiznia
1 reference
C Mitchell
1 reference
J A Church
1 reference
J Sleasman
1 reference
R Van Dyke
1 reference
C G Richardson
1 reference
A Cutrell
1 reference
W Spreen
1 reference
S Hetherington
1 reference
1 January 2001
1 reference
1 reference
107
1 reference
1
1 reference
E4
1 reference
Identifiers
1 reference
1 reference